Preclinical Study Shows Base Editing Can Correct HMSN-P Mutation
Researchers from CiRA, RIKEN, Tokushima University, and Kobe University demonstrated proof of concept for base editing aimed at the TFG P285L variant that causes HMSN-P. The study examined mouse models and neuromuscular organoids derived from patients. The findings remain at the basic research and preclinical stage and do not yet represent a treatment option.